PHARMACEUTICAL Defence Limited (PDL) has issued advice to pharmacists about the administration of the FluMist intranasal flu vaccine.
It reminds pharmacists that the vaccine must be delivered by a qualified pharmacist immuniser, and that the intranasal version is within their scope of practice.
Accurate documentation, correct technique, appropriate post-vaccination care and upload to the Australian Immunisation Register are essential.
"Pharmacists should apply the same considerations as those for the traditional intramuscular vaccine," the insurer stated.
"At a minimum, ensure:
* Maintenance of current qualifications and immunisation competencies
* Robust pre- and post-vaccination procedures
* Correct cold chain management
* Adherence to jurisdictional authorisation, approved product information and relevant guidelines
* Verification of approved age range and contraindications
* Thorough documentation of consent, administration, near misses/incidents and AIR reporting."
PDL recommends pharmacists consult their local health department for advice on funding, age eligibility and scope arrangements, as they differ by jurisdiction.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Mar 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Mar 26
